Deciphera Pharmaceuticals (Schweiz) AG

Pharmaceuticals · Zug, Zug

Deciphera Pharmaceuticals (Schweiz) AG is a Swiss pharmaceuticals company based in Zug, Canton of Zug, listed in the Swiss commercial register since 2019 (UID CHE-190.700.738). It is a subsidiary of Deciphera Pharmaceuticals.

Legal nameDeciphera Pharmaceuticals (Schweiz) AG
AddressDammstrasse, Zug
UID / VATCHE-190.700.738
Legal form · StatusAG · Active · 2019
Parent companyDeciphera Pharmaceuticals

Board members & signatories

  • Simona Greco — Präsident des Verwaltungsrates
  • Dr. Alexander Gutmans — Mitglied des Verwaltungsrates

Registered purpose

Entwicklung, Herstellung, Bezug und Vertrieb pharmazeutischer Produkte; vollständige Zweckumschreibung gemäss Statuten…

🔒 Website🔒 Employees🔒 Revenue estimate

Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026

What Deciphera Pharmaceuticals (Schweiz) does

OFFERING

Deciphera Pharmaceuticals (Schweiz) AG develops and delivers medicines for cancer treatment, focusing on switch-control kinase inhibitors. Their pipeline includes drug candidates such as Ripretinib, Vimseltinib, DCC-3009, Inlexisertib, and DCC-2812, aimed at improving patient outcomes.

Unlock the full analysis →

Similar companies

Find every pharmaceuticals company in Switzerland

Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.

family-owned pharmaceuticals companies with 50+ employees…Search →

Full profiles from CHF 49/month · Cancel anytime